Ask AI
ProCE Banner Activity

Neoadjuvant Immune Checkpoint Blockade for Muscle-Invasive Bladder Cancer

Slideset Download
In this downloadable slideset, Matthew Galsky, MD, reviews the most recent data and ongoing clinical trials assessing the efficacy of immune checkpoint inhibitor-based therapy for patients with muscle-invasive bladder cancer.

Released: November 07, 2019

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Genentech TEXT Only

Faculty Disclosure

Primary Author

Matthew Galsky, MD

Lillian and Howard Stratton Professor of Medicine
Icahn School of Medicine at Mount Sinai
Director, Genitourinary Medical Oncology
Co-Leader, Cancer Clinical Investigation Program
Associate Director for Translational Research
Tisch Cancer Institute
New York, New York